Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TreatPelade: Low Dose IL2 for Alopecia Areata
NCT02557074Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Dec 2015
- Primary completion
- Feb 2019
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alopecia areata comparing IL2 - Group A with Placebo - Group B (2 arms). Primary endpoint: Severity of Alopecia Tool. Started Dec 2015; status: completed.
02
Drugs
aldesleukin
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT02557074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02557074.